Biotronik, a worldwide leader in manufacturing cardiac medical devices, presents the innovative new Lumax 540 VR-T DX single-chamber implantable cardiac defibrillator (ICD) and Linoxsmart S DX cardiac lead system.
The Lumax DX system uniquely expands the diagnostic capabilities of the standard single-chamber ICD by integrating special atrial sensors and advanced discrimination algorithms. The Lumax DX serves a previously unmet need for cardiac device patients who are candidates for a single-chamber ICD. Standard single-chamber ICDs are designed only to sense changes in ventricular rhythm and are unable to correctly sense atrial arrhythmias such as atrial fibrillation correctly, which increases the risk of inappropriate shock or could potentially result in the patient having a stroke.
Signals coming from the atrial chambers of a patient's heart can now be sensed by the floating atrial dipole of the Linoxsmart S DX ICD lead and are amplified by a modified atrial input stage of the Lumax 540 VR-T DX device. The complementary atrial information ensures accurate sensing capabilities and provides unique protection for single-chamber ICD patients.
Enhanced arrhythmia diagnosis. Unlike standard single-chamber ICDs, the Lumax DX system provides atrial electrograms in addition to the standard ventricular ones. The physician is able to use recordings of a three-channel IEGM, showing atrial, ventricular, and far-field signals in high resolution to better determine the origin of the tachycardia and to increase treatment efficiency.
Safe shock reduction. Because standard single-chamber ICDs use only ventricular information and ignore atrial events to make therapy decisions, they may misclassify these as ventricular tachycardias and deliver inappropriate shocks. Lumax 540 VR-TDX can discriminate supraventricular tachycardias, atrial fibrillation, and atrial flutter with its SMART Detection algorithm, helping to safely reduce this risk.
Optimized atrial fibrillation management. Biotronik Home Monitoring is the world's most proven and advanced cardiac remote monitoring system, allowing physicians to remotely follow their Lumax 540 VR-T DX patients' clinical and device statuses at any time from anywhere in the world. In addition to the usual ventricular information of their single-chamber ICD patients, they now have access to complete atrial fibrillation and heart failure diagnostic data, which significantly improves early detection for reduced risk of stroke.
Source: Biotronik (www.biotronik.com)
World's Only Single-Chamber Implantable Defibrillator
Source:Ringier Release Date:2011-08-17 129
You May Like